Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti‐Ro/Sjögren Syndrome–Related Antigen A Antibodies
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.034893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Pietro Enea Lazzerini und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences Surgery and Neurosciences, Division of Internal Medicine and Geriatrics, Electroimmunology Unit University of Siena Si…. Hauptthemen laut MEDLINE: Atrioventricular Block, Calcium Channels, L-Type, Antibodies, Antinuclear, Athletes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Advanced atrioventricular block (AVB), that is, higher than second‐degree Mobitz‐1, is an abnormal finding in athletes. Despite intensive investigation, in several cases the pathogenesis remains unknown, but frequently pacemaker implantation is still indicated. Increasing evidence points to circulating anti‐Ro/Sjögren syndrome–related antigen A (SSA) antibodies cross‐reacting with L‐type calcium channel and inhibiting the related current as an epidemiologically relevant and potentially reversible cause of isolated AVB in adults. The aim of the study was to determine the prevalence of anti‐Ro/SSA‐associated advanced AVBs in a large sample of young athletes. Methods and Results A total of 2536 consecutive athletes aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences Surgery and Neurosciences, Division of Internal Medicine and Geriatrics, Electroimmunology Unit University of Siena Siena Italy.
- Cardiology Intensive Therapy Unit Department of Internal Medicine Nuovo Ospedale San Giovanni di Dio Florence Italy.
- Former Cardiology Intensive Therapy Unit, Department of Internal Medicine Hospital of Carrara Carrara Italy.
- Department of Medical Biotechnologies University of Siena Siena Italy.
- VA New York Harbor Healthcare System SUNY Downstate Health Sciences University New York NY USA.
- Center for Sports Medicine of Carrara ASL Nord-Ovest Toscana Massa-Carrara Italy.
ORCID-Profile: Pietro Enea Lazzerini, Alessandra Cartocci, Vamsi Krishna Murthy Ginjupalli, Giovanni Merico, Riccardo Accioli, Fabio Salvadori, Tommaso Marzotti, Gabriele Cevenini, Matteo Capecchi, Silvia Cantara, Anna Cantore, Maria Infantino, Francesco Finizola, Flavio D'ascenzi, Franco Laghi-Pasini, Maurizio Acampa, Pier Leopoldo Capecchi, Mohamed Boutjdir
Zitieren
APA
Lazzerini, P. E., Bertolozzi, I., Cartocci, A., Ginjupalli, V. K. M., Teneggi, P. A., Pica, D., Merico, G., Bogazzi, I., Salvini, V., Accioli, R., Salvadori, F., Marzotti, T., Cevenini, G., Capecchi, M., Cantara, S., Cantore, A., Infantino, M., Bisogno, S., Finizola, F., …, & Boutjdir, M. (2024). Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti‐Ro/Sjögren Syndrome–Related Antigen A Antibodies. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034893
Vancouver
Lazzerini PE, Bertolozzi I, Cartocci A, Ginjupalli VKM, Teneggi PA, Pica D, et al. Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti‐Ro/Sjögren Syndrome–Related Antigen A Antibodies. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.034893
BibTeX
@article{Lazzerini2024,
author = {Lazzerini, Pietro Enea and Bertolozzi, Iacopo and Cartocci, Alessandra and Ginjupalli, Vamsi Krishna Murthy and Teneggi, Pietro Alberto and Pica, Davide and Merico, Giovanni and Bogazzi, Irene and Salvini, Viola and Accioli, Riccardo and Salvadori, Fabio and Marzotti, Tommaso and Cevenini, Gabriele and Capecchi, Matteo and Cantara, Silvia and Cantore, Anna and Infantino, Maria and Bisogno, Stefania and Finizola, Francesco and D'ascenzi, Flavio and Laghi-Pasini, Franco and Acampa, Maurizio and Capecchi, Pier Leopoldo and Boutjdir, Mohamed},
title = {Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti‐Ro/Sjögren Syndrome–Related Antigen A Antibodies},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.034893}
}
EUVIMED